Pilloxa
Pilloxa is a digital health company based in Stockholm, Sweden, dedicated to creating innovative digital and remote solutions to improve medication adherence, support clinical trials, and enhance patient care through supporting medical adherence and patient retention. They develop apps, connected aids such as smart medication doses, and provide a regulatory and legal platform for pharma to create dynamic apps that support patients and learn from user data. Their mission is to support patients in medication adherence, improve health outcomes, and facilitate clinical research by leveraging technology, data visualization, and analytics. Pilloxa collaborates with pharmaceutical companies, healthcare providers, and research institutions to deliver tailored digital solutions that seamlessly integrate into patients' lives, making medication routines easier, more engaging, and more effective.
Industries
Nr. of Employees
small (1-50)
Pilloxa
Products
Electronic multi-compartment medication dispenser
A connected medication dispenser that records dosing events and synchronizes with a mobile app and cloud platform to support adherence monitoring and reminders.
Configurable branded patient mobile app program
A modular and brandable mobile application program including medication reminders, adherence dashboards, educational content and in-app patient-reported outcome capture for patient support and research.
Electronic multi-compartment medication dispenser
A connected medication dispenser that records dosing events and synchronizes with a mobile app and cloud platform to support adherence monitoring and reminders.
Configurable branded patient mobile app program
A modular and brandable mobile application program including medication reminders, adherence dashboards, educational content and in-app patient-reported outcome capture for patient support and research.
Services
Configuration and delivery of branded, modular patient-facing mobile app programs including medication support, reminders, adherence dashboards, educational content and in-app outcome capture.
Project-based services to integrate electronic adherence measurement into clinical studies, provide investigator dashboards, remote patient monitoring workflows and comparison of electronic adherence with prescription registries.
Supply and integration of electronic multi-compartment medication dispensers with cloud services and mobile apps, including device provisioning and data synchronization for objective dosing event capture.
Provision of standardized legal, regulatory and onboarding documentation packages to support customers' internal approvals and accelerate program initiation.
Patient and caregiver interviews, co-creation workshops and implementation of behavioural engagement elements to improve usability, uptake and sustained use of digital support programs.
Management of collaborations with industry and academia, and execution of grant-funded clinical validation projects including coordination with funding bodies and external partners.
Configuration and delivery of branded, modular patient-facing mobile app programs including medication support, reminders, adherence dashboards, educational content and in-app outcome capture.
Project-based services to integrate electronic adherence measurement into clinical studies, provide investigator dashboards, remote patient monitoring workflows and comparison of electronic adherence with prescription registries.
Supply and integration of electronic multi-compartment medication dispensers with cloud services and mobile apps, including device provisioning and data synchronization for objective dosing event capture.
Provision of standardized legal, regulatory and onboarding documentation packages to support customers' internal approvals and accelerate program initiation.
Patient and caregiver interviews, co-creation workshops and implementation of behavioural engagement elements to improve usability, uptake and sustained use of digital support programs.
Management of collaborations with industry and academia, and execution of grant-funded clinical validation projects including coordination with funding bodies and external partners.
Expertise Areas
- Medication adherence solutions
- Digital patient engagement and support
- Clinical trial remote monitoring and data collection
- Connected health device integration and provisioning
Key Technologies
- Cloud-hosted SaaS architecture
- Mobile health applications
- Connected medication dispensers (electronic multi-compartment devices)
- Real-time adherence monitoring and alerting
News & Updates
iZafe Group AB (publ) has signed a letter of intent with Pilloxa AB regarding the acquisition of 100% of the shares in Pilloxa, aiming to create a new company in digital health focused on better and safer drug use.
Pilloxa has signed a collaboration to provide a digital patient support solution based on their software and smart pillbox for a trial involving patients with Type 1 Diabetes and Addison’s Disease at Sahlgrenska University Hospital.
Pilloxa announced the start of the ASTORIA study, a multicenter observational trial testing their adherence solution in patients with atrial fibrillation, funded by EU grants and supported by the University of Oslo and Bayer.
Pilloxa announced they received €580,000 from the EU’s EUROSTARS program to validate and develop digital solutions supporting medication adherence in cardiovascular disease.
Pilloxa announced a cloud-hosted platform allowing pharmaceutical companies and research teams to create branded, tailored patient support programs within their app, supporting adherence, engagement, and data collection.
Pilloxa has entered strategic partnerships with Bayer, Sandoz, and others to support medication adherence through connected devices and digital solutions, aiming to reduce non-compliance and improve health outcomes.
iZafe Group AB (publ) has signed a letter of intent with Pilloxa AB regarding the acquisition of 100% of the shares in Pilloxa, aiming to create a new company in digital health focused on better and safer drug use.
Pilloxa has signed a collaboration to provide a digital patient support solution based on their software and smart pillbox for a trial involving patients with Type 1 Diabetes and Addison’s Disease at Sahlgrenska University Hospital.
Pilloxa announced the start of the ASTORIA study, a multicenter observational trial testing their adherence solution in patients with atrial fibrillation, funded by EU grants and supported by the University of Oslo and Bayer.
Pilloxa announced they received €580,000 from the EU’s EUROSTARS program to validate and develop digital solutions supporting medication adherence in cardiovascular disease.
Pilloxa announced a cloud-hosted platform allowing pharmaceutical companies and research teams to create branded, tailored patient support programs within their app, supporting adherence, engagement, and data collection.
Pilloxa has entered strategic partnerships with Bayer, Sandoz, and others to support medication adherence through connected devices and digital solutions, aiming to reduce non-compliance and improve health outcomes.